In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
NeoTherapeutics receives Notice of Allowance for additional US patent
Boston Life Sciences initiates nerve regeneration program
NeoTherapeutics' NeoGene Signs License Agreement with Pfizer
NeoTherapeutics forms subsidiary, NeoGene Technologies
NeoTherapeutics announces Alzheimer's clinical trial
NEW PATENT FOR THE TREATMENT OF DIABETES COMPLICATION EXCLUSIVELY LICENSED BY DIAMYD
DepoMed issued drug delivery patent